HomeGLABF • OTCMKTS
add
Gemina Laboratories Ltd
Previous close
$0.61
Year range
$0.24 - $0.92
Market cap
62.02M CAD
Avg Volume
1.03K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.40M | 34.42% |
Net income | -1.42M | -86.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.39M | -34.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 703.00 | -28.99% |
Total assets | 1.44M | -1.24% |
Total liabilities | 5.87M | 93.11% |
Total equity | -4.44M | — |
Shares outstanding | 76.57M | — |
Price to book | -10.20 | — |
Return on assets | -235.17% | — |
Return on capital | 135.13% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -1.42M | -86.54% |
Cash from operations | -35.82K | -533.75% |
Cash from investing | 18.42K | 13.29% |
Cash from financing | -23.51K | 11.03% |
Net change in cash | -40.91K | -2,045.20% |
Free cash flow | 487.55K | 28.38% |
About
Founded
2017
Headquarters
Website
Employees
6
